Efficiency of photodynamic treatment in patients with early gastric cancer

<p>The experience of photodynamic therapy for early gastric cancer is described in the article. The treatment results in 68 patients who were excluded for convenient surgical treatment because of advanced age or severe co-morbidity are represented. 63 patients had single tumor, 5 patients – 2...

Full description

Bibliographic Details
Main Authors: Е. V. Filonenko, V. V. Sokolov, Е. S. Karpova
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2013-01-01
Series:Biomedical Photonics
Subjects:
Online Access:http://www.pdt-journal.com:80/jour/article/view/10
_version_ 1818562073305546752
author Е. V. Filonenko
V. V. Sokolov
Е. S. Karpova
author_facet Е. V. Filonenko
V. V. Sokolov
Е. S. Karpova
author_sort Е. V. Filonenko
collection DOAJ
description <p>The experience of photodynamic therapy for early gastric cancer is described in the article. The treatment results in 68 patients who were excluded for convenient surgical treatment because of advanced age or severe co-morbidity are represented. 63 patients had single tumor, 5 patients – 2 tumors. Four Russian agents: photogem, photosens, radaсhlorin and alasens, were used for photodynamic therapy. The treatment session was performed under local anesthesia during routine endoscopy with diode laser with wavelength consistent with photosensitizer (photogem – 630 nm, photosens – 670 nm, alasens-induced protoporphyrin IX – 635 nm, radaсhlorin – 662 nm). The short-term results were analyzed 1 month after treatment according to endoscopy, morphological study, CT, ultrasound or endosonography. For 73 lesions complete regression was observed in 53 (72.6%) and partial regression in 20 tumors (27.4%). The efficacy of photodynamic therapy was shown to be directly associated with tumor size. Thus, for tumors up to 1 cm regression occurred in 100% of cases, up to 1.5 cm – in 70.8%, up to 3 cm – in 65.2%, up to 5 cm – in 58.3%. The median survival rates accounted for 7.31 years, 3-year survival – 83±5%, 5-year - 69±8%. The experience showed that the developed method of photodynamic therapy was promising in treatment for early gastric cancer as an alternative to surgery.</p><p> </p>
first_indexed 2024-12-14T00:58:55Z
format Article
id doaj.art-38bd7fa3b1b94a859a8b09798063d04a
institution Directory Open Access Journal
issn 2413-9432
language Russian
last_indexed 2024-12-14T00:58:55Z
publishDate 2013-01-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj.art-38bd7fa3b1b94a859a8b09798063d04a2022-12-21T23:23:22ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322013-01-01223710Efficiency of photodynamic treatment in patients with early gastric cancerЕ. V. Filonenko0V. V. Sokolov1Е. S. Karpova2Национальный медицинский исследовательский радиологический центр Минздрава России, Москва, Россия; Первый Московский государственный медицинский университет им. И.М. Сеченова, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, РоссияНациональный медицинский исследовательский радиологический центр Минздрава России, Москва, Россия<p>The experience of photodynamic therapy for early gastric cancer is described in the article. The treatment results in 68 patients who were excluded for convenient surgical treatment because of advanced age or severe co-morbidity are represented. 63 patients had single tumor, 5 patients – 2 tumors. Four Russian agents: photogem, photosens, radaсhlorin and alasens, were used for photodynamic therapy. The treatment session was performed under local anesthesia during routine endoscopy with diode laser with wavelength consistent with photosensitizer (photogem – 630 nm, photosens – 670 nm, alasens-induced protoporphyrin IX – 635 nm, radaсhlorin – 662 nm). The short-term results were analyzed 1 month after treatment according to endoscopy, morphological study, CT, ultrasound or endosonography. For 73 lesions complete regression was observed in 53 (72.6%) and partial regression in 20 tumors (27.4%). The efficacy of photodynamic therapy was shown to be directly associated with tumor size. Thus, for tumors up to 1 cm regression occurred in 100% of cases, up to 1.5 cm – in 70.8%, up to 3 cm – in 65.2%, up to 5 cm – in 58.3%. The median survival rates accounted for 7.31 years, 3-year survival – 83±5%, 5-year - 69±8%. The experience showed that the developed method of photodynamic therapy was promising in treatment for early gastric cancer as an alternative to surgery.</p><p> </p>http://www.pdt-journal.com:80/jour/article/view/10ранний рак желудкафотодинамическая терапияфотогемфотосенсрадахлориналасенс
spellingShingle Е. V. Filonenko
V. V. Sokolov
Е. S. Karpova
Efficiency of photodynamic treatment in patients with early gastric cancer
Biomedical Photonics
ранний рак желудка
фотодинамическая терапия
фотогем
фотосенс
радахлорин
аласенс
title Efficiency of photodynamic treatment in patients with early gastric cancer
title_full Efficiency of photodynamic treatment in patients with early gastric cancer
title_fullStr Efficiency of photodynamic treatment in patients with early gastric cancer
title_full_unstemmed Efficiency of photodynamic treatment in patients with early gastric cancer
title_short Efficiency of photodynamic treatment in patients with early gastric cancer
title_sort efficiency of photodynamic treatment in patients with early gastric cancer
topic ранний рак желудка
фотодинамическая терапия
фотогем
фотосенс
радахлорин
аласенс
url http://www.pdt-journal.com:80/jour/article/view/10
work_keys_str_mv AT evfilonenko efficiencyofphotodynamictreatmentinpatientswithearlygastriccancer
AT vvsokolov efficiencyofphotodynamictreatmentinpatientswithearlygastriccancer
AT eskarpova efficiencyofphotodynamictreatmentinpatientswithearlygastriccancer